Works matching AU Holst, Jens J.
Results: 479
Determinants of Fasting Hyperglucagonemia in Patients with Type 2 Diabetes and Nondiabetic Control Subjects.
- Published in:
- Metabolic Syndrome & Related Disorders, 2018, v. 16, n. 10, p. 530, doi. 10.1089/met.2018.0066
- By:
- Publication type:
- Article
A randomized, double‐blind, crossover study of the effect of the fluoroquinolone moxifloxacin on glucose levels and insulin sensitivity in young men and women.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 1, p. 98, doi. 10.1111/dom.14851
- By:
- Publication type:
- Article
The effect of curcumin on hepatic fat content in individuals with obesity.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 11, p. 2192, doi. 10.1111/dom.14804
- By:
- Publication type:
- Article
Acute effects on glucose tolerance by neprilysin inhibition in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 10, p. 2017, doi. 10.1111/dom.14789
- By:
- Publication type:
- Article
Acute concomitant glucose‐dependent insulinotropic polypeptide receptor antagonism during glucagon‐like peptide 1 receptor agonism does not affect appetite, resting energy expenditure or food intake in patients with type 2 diabetes and overweight/obesity
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 9, p. 1882, doi. 10.1111/dom.14736
- By:
- Publication type:
- Article
Measurement of plasma glucagon in humans: A shift in the performance of a current commercially available radioimmunoassay kit.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 6, p. 1182, doi. 10.1111/dom.14673
- By:
- Publication type:
- Article
Acute effects of linagliptin on intact and total glucagon‐like peptide‐1 and gastric inhibitory polypeptide levels in insulin‐dependent type 2 diabetes patients with and without moderate renal impairment.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 5, p. 806, doi. 10.1111/dom.14636
- By:
- Publication type:
- Article
Effects of short‐acting exenatide added three times daily to insulin therapy on bone metabolism in type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 2, p. 221, doi. 10.1111/dom.14568
- By:
- Publication type:
- Article
Postprandial renal haemodynamic effects of the dipeptidyl peptidase‐4 inhibitor linagliptin versus the sulphonylurea glimepiride in adults with type 2 diabetes (RENALIS): A predefined substudy of a randomized, double‐blind trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 1, p. 115, doi. 10.1111/dom.14557
- By:
- Publication type:
- Article
Glucose‐dependent insulinotropic polypeptide induces lipolysis during stable basal insulin substitution and hyperglycaemia in men with type 1 diabetes: A randomized, double‐blind, placebo‐controlled, crossover clinical trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 1, p. 142, doi. 10.1111/dom.14545
- By:
- Publication type:
- Article
Do sodium‐glucose co‐transporter‐2 inhibitors increase plasma glucagon by direct actions on the alpha cell? And does the increase matter for the associated increase in endogenous glucose production?
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 9, p. 2009, doi. 10.1111/dom.14422
- By:
- Publication type:
- Article
Acute ketosis inhibits appetite and decreases plasma concentrations of acyl ghrelin in healthy young men.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1834, doi. 10.1111/dom.14402
- By:
- Publication type:
- Article
Gastric emptying of solutions containing the natural sweetener erythritol and effects on gut hormone secretion in humans: A pilot dose‐ranging study.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 6, p. 1311, doi. 10.1111/dom.14342
- By:
- Publication type:
- Article
No effects of dapagliflozin, metformin or exercise on plasma glucagon concentrations in individuals with prediabetes: A post hoc analysis from the randomized controlled PRE‐D trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 530, doi. 10.1111/dom.14246
- By:
- Publication type:
- Article
Cerebral effects of glucagon‐like peptide‐1 receptor blockade before and after Roux‐en‐Y gastric bypass surgery in obese women: A proof‐of‐concept resting‐state functional MRI study.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 415, doi. 10.1111/dom.14233
- By:
- Publication type:
- Article
Dose‐dependent efficacy of the glucose‐dependent insulinotropic polypeptide (GIP) receptor antagonist GIP(3‐30)NH<sub>2</sub> on GIP actions in humans.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 1, p. 68, doi. 10.1111/dom.14186
- By:
- Publication type:
- Article
Normal insulin sensitivity, glucose tolerance, gut incretin and pancreatic hormone responses in adults with atopic dermatitis.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2161, doi. 10.1111/dom.14146
- By:
- Publication type:
- Article
Cover Image, Volume 22, Issue 10.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1, doi. 10.1111/dom.14188
- By:
- Publication type:
- Article
No effects of a 6‐week intervention with a glucagon‐like peptide‐1 receptor agonist on pancreatic volume and oedema in obese men without diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1837, doi. 10.1111/dom.14106
- By:
- Publication type:
- Article
Is glucagon‐like peptide‐1 fully protected by the dipeptidyl peptidase 4 inhibitor sitagliptin when administered to patients with type 2 diabetes?
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 1937, doi. 10.1111/dom.13321
- By:
- Publication type:
- Article
Glucose‐lowering effects and mechanisms of the bile acid‐sequestering resin sevelamer.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 7, p. 1623, doi. 10.1111/dom.13272
- By:
- Publication type:
- Article
Erratum: Effect of GLP‐1 receptor agonist treatment on body weight in obese antipsychotic‐treated patients with schizophrenia: A randomized, placebo‐controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 5, p. 1327, doi. 10.1111/dom.13204
- By:
- Publication type:
- Article
The bile acid‐sequestering resin sevelamer eliminates the acute GLP‐1 stimulatory effect of endogenously released bile acids in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 362, doi. 10.1111/dom.13080
- By:
- Publication type:
- Article
Effect of liraglutide on ectopic fat in polycystic ovary syndrome: A randomized clinical trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 1, p. 215, doi. 10.1111/dom.13053
- By:
- Publication type:
- Article
Do we know the true mechanism of action of the DPP-4 inhibitors?
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 1, p. 34, doi. 10.1111/dom.13018
- By:
- Publication type:
- Article
Liraglutide as adjunct to insulin treatment in type 1 diabetes does not interfere with glycaemic recovery or gastric emptying rate during hypoglycaemia: A randomized, placebo-controlled, double-blind, parallel-group study.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 6, p. 773, doi. 10.1111/dom.12830
- By:
- Publication type:
- Article
Effect of GLP-1 receptor agonist treatment on body weight in obese antipsychotic-treated patients with schizophrenia: a randomized, placebo-controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 2, p. 162, doi. 10.1111/dom.12795
- By:
- Publication type:
- Article
The impact of EndoBarrier gastrointestinal liner in obese patients with normal glucose tolerance and in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 2, p. 189, doi. 10.1111/dom.12800
- By:
- Publication type:
- Article
Addition of a dipeptidyl peptidase-4 inhibitor, sitagliptin, to ongoing therapy with the glucagon-like peptide-1 receptor agonist liraglutide: A randomized controlled trial in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 2, p. 200, doi. 10.1111/dom.12802
- By:
- Publication type:
- Article
Feedback suppression of meal-induced glucagon-like peptide-1 ( GLP-1) secretion mediated through elevations in intact GLP-1 caused by dipeptidyl peptidase-4 inhibition: a randomized, prospective comparison of sitagliptin and vildagliptin treatment.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 11, p. 1100, doi. 10.1111/dom.12706
- By:
- Publication type:
- Article
The physiology and pharmacology of incretins in type 2 diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2008, v. 10, p. 14, doi. 10.1111/j.1463-1326.2008.00920.x
- By:
- Publication type:
- Article
Fiber mixture-specific effect on distal colonic fermentation and metabolic health in lean but not in prediabetic men.
- Published in:
- Gut Microbes, 2022, v. 14, n. 1, p. 1, doi. 10.1080/19490976.2021.2009297
- By:
- Publication type:
- Article
Effect of wheat bran derived prebiotic supplementation on gastrointestinal transit, gut microbiota, and metabolic health: a randomized controlled trial in healthy adults with a slow gut transit.
- Published in:
- Gut Microbes, 2021, v. 13, n. 1, p. 1, doi. 10.1080/19490976.2019.1704141
- By:
- Publication type:
- Article
Unprecedented high insulin secretion in a healthy human subject after intravenous glucagon-like peptide-1: a case report.
- Published in:
- 2014
- By:
- Publication type:
- Case Study
The Authors Reply:.
- Published in:
- Kidney International, 2014, v. 85, n. 1, p. 212, doi. 10.1038/ki.2013.410
- By:
- Publication type:
- Article
Gastrointestinal factors contribute to glucometabolic disturbances in nondiabetic patients with end-stage renal disease.
- Published in:
- Kidney International, 2013, v. 83, n. 5, p. 915, doi. 10.1038/ki.2012.460
- By:
- Publication type:
- Article
Methods and Guidelines for Measurement of Glucagon in Plasma.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 21, p. 5416, doi. 10.3390/ijms20215416
- By:
- Publication type:
- Article
Glucagon Receptor Signaling and Glucagon Resistance.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 13, p. 3314, doi. 10.3390/ijms20133314
- By:
- Publication type:
- Article
Greater glucagon-like peptide-1 responses to oral glucose are associated with lower central and peripheral blood pressures.
- Published in:
- Cardiovascular Diabetology, 2019, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12933-019-0937-7
- By:
- Publication type:
- Article
Adults with pathogenic MC4R mutations have increased final height and thereby increased bone mass.
- Published in:
- 2020
- By:
- Publication type:
- journal article
High-Dose Glucagon Has Hemodynamic Effects Regardless of Cardiac Beta-Adrenoceptor Blockade: A Randomized Clinical Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Circulating but not faecal short-chain fatty acids are related to insulin sensitivity, lipolysis and GLP-1 concentrations in humans.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-48775-0
- By:
- Publication type:
- Article
Glucose- and Bile Acid-Stimulated Secretion of Gut Hormones in the Isolated Perfused Intestine Is Not Impaired in Diet-Induced Obese Mice.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.884501
- By:
- Publication type:
- Article
The intestinal distribution pattern of appetite- and glucose regulatory peptides in mice, rats and pigs.
- Published in:
- BMC Research Notes, 2016, v. 9, p. 1, doi. 10.1186/s13104-016-1872-2
- By:
- Publication type:
- Article
Weight loss by calorie restriction does not alter appetite‐regulating gut hormone responses from perfused rat small intestine.
- Published in:
- Acta Physiologica, 2023, v. 238, n. 1, p. 1, doi. 10.1111/apha.13947
- By:
- Publication type:
- Article
In the rat pancreas, somatostatin tonically inhibits glucagon secretion and is required for glucose‐induced inhibition of glucagon secretion.
- Published in:
- Acta Physiologica, 2020, v. 229, n. 3, p. 1, doi. 10.1111/apha.13464
- By:
- Publication type:
- Article
Hyperosmolar Duodenal Saline Infusion Lowers Circulating Ghrelin and Stimulates Intestinal Hormone Release in Young Men.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Older Subjects With ß-Cell Dysfunction Have an Accentuated Incretin Release.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2018, v. 103, n. 7, p. 2613, doi. 10.1210/jc.2018-00260
- By:
- Publication type:
- Article
Older Subjects With β-Cell Dysfunction Have an Accentuated Incretin Release.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Single-Dose Metformin Enhances Bile Acid–Induced Glucagon-Like Peptide-1 Secretion in Patients With Type 2 Diabetes.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2017, p. 4153, doi. 10.1210/jc.2017-01091
- By:
- Publication type:
- Article